Ethics roundtable: Using new, expensive drugs
Costly genetically engineered therapies, which threaten to cripple the health care industry economy and undermine the common good if applied indiscriminately, loom on the horizon. The spectrum of applicable candidates include moribund nursing home patients at the end of life. They will be fair game...
Na minha lista:
| Udgivet i: | Crit Care |
|---|---|
| Principais autores: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2002
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC153428/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12493067/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1533 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
